Modernizing Medicine

Modernizing Medicine, founded in 2010 by Daniel Cane and Michael Sherling, has raised $329M across multiple rounds, including a $231M Series F in 2017, $38M Series E in 2015, and $10M venture debt in 2015. The company provides specialty-specific EMR (EMA) and practice management solutions using AI to automate charting, coding, and clinical workflows. Funding supported product verticalization, telehealth, interoperability, analytics, and M&A to broaden clinical offerings. Employing approximately 1,563 people, Modernizing Medicine serves dermatology, ophthalmology, gastroenterology, and other specialty practices, with key investors including Warburg Pincus, Summit Partners, Pentland, Sands Capital Ventures, and SVB.